Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KS-SVF-1002
- Development stage
- Unknown
- Lead developer
- Kimera Society
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
KS-SVF-1002 is an autologous adipose-derived stem cell (ASC) therapy developed by Kimera Society for the treatment of chronic obstructive pulmonary disease (COPD). The therapeutic process involves extracting adipose tissue from the patient via liposuction, followed by the isolation of the non-cultured stromal vascular fraction (SVF) which contains a population of regenerative stem cells. These cells are then re-introduced into the patient's system through intravenous injection. The therapy aims to exploit the natural immunomodulatory and anti-inflammatory capabilities of ASCs to reduce systemic and pulmonary inflammation, potentially improving lung function and exercise tolerance. Clinical evaluation focuses on safety and efficacy endpoints such as forced expiratory volume in one second (FEV1) and the 6-minute walk distance (6MWD) test.
- Other names
- Adipose Derived Stem Cell TherapyAdipose Derived Stem Cell (ADSC) TherapyAutologous Adipose-derived Stem Cells
Beyond the preview
Go deeper on KS-SVF-1002.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KS-SVF-1002.